{"id":13993,"date":"2026-03-23T08:43:52","date_gmt":"2026-03-23T07:43:52","guid":{"rendered":"https:\/\/leo-foundation.org\/en\/?p=13993"},"modified":"2026-03-23T08:43:53","modified_gmt":"2026-03-23T07:43:53","slug":"the-leo-foundation-appoints-new-board-members","status":"publish","type":"post","link":"https:\/\/leo-foundation.org\/en\/2026\/03\/23\/the-leo-foundation-appoints-new-board-members\/","title":{"rendered":"The LEO Foundation appoints new board members"},"content":{"rendered":"\n
\n
<\/div>\n\n\n\n

Press release, 23 March 2026<\/em><\/em><\/p>\n\n\n\n

The LEO Foundation has appointed Tina Sejersg\u00e5rd Fan\u00f8, Executive Vice President at Novonesis, and Adam Steensberg, CEO of Zealand Pharma, to its Board of Trustees at the Annual Meeting on 20 March 2026. Three employee-elected members have also joined the Board.<\/h3>\n\n\n\n
<\/div>\n\n\n\n

New board members<\/strong><\/p>\n\n\n\n